The aryl hydrocarbon receptor is required for developmental closure of the ductus venosus in the neonatal mouse

Garet Lahvis, Robert W. Pyzalski, Edward Glover, Henry C. Pitot, Matthew K. McElwee, Christopher A. Bradfield

Research output: Contribution to journalArticle

118 Citations (Scopus)

Abstract

A developmental role for the Ahr locus has been indicated by the observation that mice harboring a null allele display a portocaval vascular shunt throughout life. To define the ontogeny and determine the identity of this shunt, we developed a visualization approach in which three-dimensional (3D) images of the developing liver vasculature are generated from serial sections. Applying this 3D visualization approach at multiple developmental times allowed us to demonstrate that the portocaval shunt observed in Ahr-null mice is the remnant of an embryonic structure and is not acquired after birth. We observed that the shunt is found in late-stage wild-type embryos but closes during the first 48 h of postnatal life. In contrast, the same structure fails to close in Ahr-null mice and remains open throughout adulthood. The ontogeny of this shunt, along with its 3D position, allowed us to conclude that this shunt is a patent developmental structure known as the ductus venosus (DV). Upon searching for a physiological cause of the patent DV, we observed that during the first 48 h, most major hepatic veins, such as the portal and umbilical veins, normally decrease in diameter but do not change in Ahr-null mice. This observation suggests that failure of the DV to close may be the consequence of increased blood pressure or a failure in vasoconstriction in the developing liver.

Original languageEnglish (US)
Pages (from-to)714-720
Number of pages7
JournalMolecular Pharmacology
Volume67
Issue number3
DOIs
StatePublished - Mar 2005
Externally publishedYes

Fingerprint

Aryl Hydrocarbon Receptors
Embryonic Structures
Umbilical Veins
Hepatic Veins
Three-Dimensional Imaging
Liver
Portal Vein
Vasoconstriction
Blood Vessels
Alleles
Parturition
Blood Pressure

ASJC Scopus subject areas

  • Pharmacology

Cite this

The aryl hydrocarbon receptor is required for developmental closure of the ductus venosus in the neonatal mouse. / Lahvis, Garet; Pyzalski, Robert W.; Glover, Edward; Pitot, Henry C.; McElwee, Matthew K.; Bradfield, Christopher A.

In: Molecular Pharmacology, Vol. 67, No. 3, 03.2005, p. 714-720.

Research output: Contribution to journalArticle

Lahvis, Garet ; Pyzalski, Robert W. ; Glover, Edward ; Pitot, Henry C. ; McElwee, Matthew K. ; Bradfield, Christopher A. / The aryl hydrocarbon receptor is required for developmental closure of the ductus venosus in the neonatal mouse. In: Molecular Pharmacology. 2005 ; Vol. 67, No. 3. pp. 714-720.
@article{423ecc42ea2d4b52b5b037b061a2ea1e,
title = "The aryl hydrocarbon receptor is required for developmental closure of the ductus venosus in the neonatal mouse",
abstract = "A developmental role for the Ahr locus has been indicated by the observation that mice harboring a null allele display a portocaval vascular shunt throughout life. To define the ontogeny and determine the identity of this shunt, we developed a visualization approach in which three-dimensional (3D) images of the developing liver vasculature are generated from serial sections. Applying this 3D visualization approach at multiple developmental times allowed us to demonstrate that the portocaval shunt observed in Ahr-null mice is the remnant of an embryonic structure and is not acquired after birth. We observed that the shunt is found in late-stage wild-type embryos but closes during the first 48 h of postnatal life. In contrast, the same structure fails to close in Ahr-null mice and remains open throughout adulthood. The ontogeny of this shunt, along with its 3D position, allowed us to conclude that this shunt is a patent developmental structure known as the ductus venosus (DV). Upon searching for a physiological cause of the patent DV, we observed that during the first 48 h, most major hepatic veins, such as the portal and umbilical veins, normally decrease in diameter but do not change in Ahr-null mice. This observation suggests that failure of the DV to close may be the consequence of increased blood pressure or a failure in vasoconstriction in the developing liver.",
author = "Garet Lahvis and Pyzalski, {Robert W.} and Edward Glover and Pitot, {Henry C.} and McElwee, {Matthew K.} and Bradfield, {Christopher A.}",
year = "2005",
month = "3",
doi = "10.1124/mol.104.008888",
language = "English (US)",
volume = "67",
pages = "714--720",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - The aryl hydrocarbon receptor is required for developmental closure of the ductus venosus in the neonatal mouse

AU - Lahvis, Garet

AU - Pyzalski, Robert W.

AU - Glover, Edward

AU - Pitot, Henry C.

AU - McElwee, Matthew K.

AU - Bradfield, Christopher A.

PY - 2005/3

Y1 - 2005/3

N2 - A developmental role for the Ahr locus has been indicated by the observation that mice harboring a null allele display a portocaval vascular shunt throughout life. To define the ontogeny and determine the identity of this shunt, we developed a visualization approach in which three-dimensional (3D) images of the developing liver vasculature are generated from serial sections. Applying this 3D visualization approach at multiple developmental times allowed us to demonstrate that the portocaval shunt observed in Ahr-null mice is the remnant of an embryonic structure and is not acquired after birth. We observed that the shunt is found in late-stage wild-type embryos but closes during the first 48 h of postnatal life. In contrast, the same structure fails to close in Ahr-null mice and remains open throughout adulthood. The ontogeny of this shunt, along with its 3D position, allowed us to conclude that this shunt is a patent developmental structure known as the ductus venosus (DV). Upon searching for a physiological cause of the patent DV, we observed that during the first 48 h, most major hepatic veins, such as the portal and umbilical veins, normally decrease in diameter but do not change in Ahr-null mice. This observation suggests that failure of the DV to close may be the consequence of increased blood pressure or a failure in vasoconstriction in the developing liver.

AB - A developmental role for the Ahr locus has been indicated by the observation that mice harboring a null allele display a portocaval vascular shunt throughout life. To define the ontogeny and determine the identity of this shunt, we developed a visualization approach in which three-dimensional (3D) images of the developing liver vasculature are generated from serial sections. Applying this 3D visualization approach at multiple developmental times allowed us to demonstrate that the portocaval shunt observed in Ahr-null mice is the remnant of an embryonic structure and is not acquired after birth. We observed that the shunt is found in late-stage wild-type embryos but closes during the first 48 h of postnatal life. In contrast, the same structure fails to close in Ahr-null mice and remains open throughout adulthood. The ontogeny of this shunt, along with its 3D position, allowed us to conclude that this shunt is a patent developmental structure known as the ductus venosus (DV). Upon searching for a physiological cause of the patent DV, we observed that during the first 48 h, most major hepatic veins, such as the portal and umbilical veins, normally decrease in diameter but do not change in Ahr-null mice. This observation suggests that failure of the DV to close may be the consequence of increased blood pressure or a failure in vasoconstriction in the developing liver.

UR - http://www.scopus.com/inward/record.url?scp=14944374033&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14944374033&partnerID=8YFLogxK

U2 - 10.1124/mol.104.008888

DO - 10.1124/mol.104.008888

M3 - Article

C2 - 15590894

AN - SCOPUS:14944374033

VL - 67

SP - 714

EP - 720

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 3

ER -